Oprelvekin (rHuIL-11)

Product description

Oprelvekin is a recombinant human interleukin 11, produced by recombinant DNA technology using E.coli. It has a molecular weight of approximately 19.0kD, non-glycosylated. The polypeptide is 177 amino acids and differs from the 178 amino acid length of native IL-11 only in lacking the amino-terminal protein residue, this alteration has not resulted in measurable differences in bioactivity either in vitro or in vivo.brhrbrAppearance Properties: Sterile and white lyophilized powder to be reconstituted with a diluent (Sterile Water for Injection) for injection, presented in vials.

Specifications: 1mg/vial, 1.5mg/vial, 2mg/vial, 3mg/vial and 5mg/vial

Indications:
Oprelvekin is indicated for severe thrombocytopenia with degree III and IV induced by chemotherapy to solid tumor and to non-marrow leukemia. It could be administered together with rHuG-CSF to treat patients with leucopenia.
Read more

Specifications

Categories Biopharmaceuticals
Supplied from China

More products from Xiamen Amoytop Biotech Co. Ltd

View all our products (26)

Products from other suppliers

Oprelvekin (rHuIL-11)

Contact information

Address

Telephone

Website

View all contact information
Tjoapack

Tjoapack

Bachem CMC Development and Commercial APIs

Bachem CMC Development and Commercial APIs

Discover Innovation with Softigel by Procaps

Discover Innovation with Softigel by Procaps

Discover The Difference of BD Solutions at Hospital, at Outpatient Clinic and at Home

Discover "The Difference" of BD Solutions at Hospital, at Outp...

Nanoform - an innovative nanoparticle medicine enabling company

Nanoform - an innovative nanoparticle medicine enabling company